Literature DB >> 2162064

Leukotriene B4 and prostaglandin E2-like activity in synovial fluid in osteoarthritis.

O Sahap Atik1.   

Abstract

LTB4 and PGE2-like activity in synovial fluid samples from patients with osteoarthritis of the knee joint were determined and found to be significantly higher than in samples obtained from normal patients. The results suggest that leukotrienes and prostaglandins may have a role in the pathogenesis of osteoarthritis.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2162064     DOI： 10.1016/0952-3278(90)90002-3

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN： 0952-3278            Impact factor:   4.006


  11 in total

Review 1.  Why are non-steroidal anti-inflammatory drugs so variable in their efficacy? A description of ion trapping.

Authors:  G A Ellis; D R Blake
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

2.  Anti-arthritic activity of agnuside mediated through the down-regulation of inflammatory mediators and cytokines.

Authors:  Anjali Pandey; Sarang Bani; Naresh Kumar Satti; Bishan Dutt Gupta; Krishan Avtar Suri
Journal:  Inflamm Res       Date:  2012-01-08       Impact factor: 4.575

3.  Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture.

Authors:  A J de Brum-Fernandes; S Morisset; G Bkaily; C Patry
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

Review 4.  Persisting eicosanoid pathways in rheumatic diseases.

Authors:  Marina Korotkova; Per-Johan Jakobsson
Journal:  Nat Rev Rheumatol       Date:  2014-02-11       Impact factor: 20.543

5.  Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac.

Authors:  M A Alvarez-Soria; R Largo; J Santillana; O Sánchez-Pernaute; E Calvo; M Hernández; J Egido; G Herrero-Beaumont
Journal:  Ann Rheum Dis       Date:  2006-02-13       Impact factor: 19.103

Review 6.  Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis.

Authors:  Manon C Zweers; Tineke N de Boer; Joël van Roon; Johannes W J Bijlsma; Floris P J G Lafeber; Simon C Mastbergen
Journal:  Arthritis Res Ther       Date:  2011-09-21       Impact factor: 5.156

Review 7.  Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis.

Authors:  S B Abramson; M Attur; A R Amin; R Clancy
Journal:  Curr Rheumatol Rep       Date:  2001-12       Impact factor: 4.686

Review 8.  ADAMTS-12: a multifaced metalloproteinase in arthritis and inflammation.

Authors:  Jianlu Wei; Brendon Richbourgh; Tanghong Jia; Chuanju Liu
Journal:  Mediators Inflamm       Date:  2014-04-28       Impact factor: 4.711

9.  Analgesic effect of S (+)-flurbiprofen plaster in a rat model of knee arthritis: analysis of gait and synovial fluid prostaglandin E2 levels.

Authors:  Ayaka Fukumoto; Kyoko Tajima; Miyuki Hori; Yoshihisa Toda; Shinsuke Kaku; Hideo Matsumoto
Journal:  J Pharm Pharmacol       Date:  2018-04-01       Impact factor: 3.765

10.  Oral administration of EP4-selective agonist KAG-308 suppresses mouse knee osteoarthritis development through reduction of chondrocyte hypertrophy and TNF secretion.

Authors:  Yasutaka Murahashi; Fumiko Yano; Ryota Chijimatsu; Hideki Nakamoto; Yuji Maenohara; Masahiro Amakawa; Yoshihide Miyake; Hiroyuki Yamanaka; Kousuke Iba; Toshihiko Yamashita; Sakae Tanaka; Taku Saito
Journal:  Sci Rep       Date:  2019-12-30       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.